Lipoprotein-Associated Phospholipase A2 Mass Level Is Increased in Elderly Subjects with Type 2 Diabetes Mellitus

Lipoprotein-Associated Phospholipase A2 Mass Level Is Increased in Elderly Subjects with Type 2 Diabetes Mellitus

Objective. Lipoprotein-associated phospholipase A2 (Lp-PLA2) is extensively expressed by advanced atherosclerotic lesions and may play a role in plaque instability. We selected a group of elderly subjects that underwent transcatheter aortic valve implantation (TAVI) or balloon angioplasty (BA) and s...

Full description

Saved in:

Bibliographic Details
Main Authors:	J. Fortunato, V. Bláha, J. Bis, J. Št’ásek, C. Andrýs, J. Vojáček, B. Jurašková, L. Sobotka, P. Polanský, M. Brtko
Format:	Article
Language:	English
Published:	Wiley 2014-01-01
Series:	Journal of Diabetes Research
Online Access:	http://dx.doi.org/10.1155/2014/278063
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Biological Properties and Clinical Significance of Lipoprotein-Associated Phospholipase A2 in Ischemic Stroke
by: Shuang Zhang, et al.
Published: (2022-01-01)

Exploring Lipoprotein-Associated Phospholipase A2 Levels in Iraqi Patients with Stable Angina: Insights from Coronary Angiography Diagnosis
by: Aseel Ghassan Daoud, et al.
Published: (2025-01-01)

Diagnostic Predictive Value of Tryptase, Serum Amyloid A and Lipoprotein-Associated Phospholipase A2 Biomarker Groups for Large Atherosclerotic Cerebral Infarction
by: Wenhui Jia, et al.
Published: (2022-01-01)

Human phospholipases A2: a functional and evolutionary analysis
by: I. I. Turnaev, et al.
Published: (2023-01-01)

Maintenance of Synaptic Stability Requires Calcium-Independent Phospholipase A2 Activity
by: Julie Allyson, et al.
Published: (2012-01-01)

Relationship of Para and Perirenal Fat and High-Density Lipoprotein and Its Function in Patients with Type 2 Diabetes Mellitus
by: Jing Ke, et al.
Published: (2021-01-01)

Vagal Blocking Improves Glycemic Control and Elevated Blood Pressure in Obese Subjects with Type 2 Diabetes Mellitus
by: S. Shikora, et al.
Published: (2013-01-01)

Elevated plasma phospholipase A2 and platelet-activating factor acetylhydrolase activity in colorectal cancer
by: Yves Denizot, et al.
Published: (2004-01-01)

Characterization of Serum Phospholipase A2 Activity in Three Diverse Species of West African Crocodiles
by: Mark Merchant, et al.
Published: (2011-01-01)

Contribution of individual phospholipase A2 enzymes to the cleavage of oxidized phospholipids in human blood plasma
by: Philipp Jokesch, et al.
Published: (2025-02-01)

A novel index for diagnosis of type 2 diabetes mellitus: Cholesterol, High density lipoprotein, and Glucose (CHG) index
by: Amin Mansoori, et al.
Published: (2025-02-01)

Insulin Resistance Predicts Atherogenic Lipoprotein Profile in Nondiabetic Subjects
by: Flávia De C. Cartolano, et al.
Published: (2017-01-01)

Phospholipase A2 Mediates Apolipoprotein-Independent Uptake of Chylomicron Remnant-Like Particles by Human Macrophages
by: Mariarosaria Napolitano, et al.
Published: (2012-01-01)

A Tentative Mechanism of Solubilization of Neuropathy Target Esterase from Chicken Embryo Brain by Phospholipase A2
by: Josef Seifert
Published: (2008-01-01)

Tenidap sodium inhibits secretory non-pancreatic phospholipase A2 synthesis by foetal rat calvarial osteoblasts
by: W. Pruzanski, et al.
Published: (1995-01-01)

Secretory phospholipase A2 inhibitory activity in Tragia hispida: A novel and promising therapeutic agent for dengue fever
by: D.V. Dayangi Hemalika, et al.
Published: (2025-02-01)

Mechanism of Cytosolic Phospholipase A2 Activation in Ghrelin Protection of Salivary Gland Acinar Cells against Ethanol Cytotoxicity
by: Bronislaw L. Slomiany, et al.
Published: (2010-01-01)

Fibrinogen-albumin ratio predicts treatment response in phospholipase A2 receptor-associated membranous nephropathy with nephrotic syndrome
by: Suyan Duan, et al.
Published: (2024-12-01)

Behaviour of Human Erythrocyte Aggregation in Presence of Autologous Lipoproteins
by: C. Saldanha, et al.
Published: (2012-01-01)

Timed Bromocriptine-QR Therapy Reduces Progression of Cardiovascular Disease and Dysglycemia in Subjects with Well-Controlled Type 2 Diabetes Mellitus
by: Bindu Chamarthi, et al.
Published: (2015-01-01)

Plasminogen Activator Inhibitor-1 Level Correlates with Lipoprotein Subfractions in Obese Nondiabetic Subjects
by: Sándor Somodi, et al.
Published: (2018-01-01)

The Role of Phospholipase C Signaling in Macrophage-Mediated Inflammatory Response
by: Liqian Zhu, et al.
Published: (2018-01-01)

Diabetes mellitus 2 in Mexico: challenge for the health system
by: Laura Moreno-Altamirano, et al.
Published: (2025-01-01)

Role of crotoxin, a phospholipase A2 isolated from Crotalus durissus terrificus snake venom, on inflammatory and immune reactions
by: Diva F. Cardoso, et al.
Published: (2001-01-01)

Involvement of different protein kinases and phospholipases A2 in phorbol ester (TPA)-induced arachidonic acid liberation in bovine platelets
by: M. Lehr, et al.
Published: (2000-01-01)

Phospholipase A2 Activity in Gingival Crevicular Fluid from Patients with Periodontal Disease: A possible Marker of Disease Activity
by: H. Ishida, et al.
Published: (1994-01-01)

Antibodies Against β2-Glycoprotein I Complexed With an Oxidised Lipoprotein Relate to Intima Thickening of Carotid Arteries in Primary Antiphospholipid Syndrome
by: P. R. J. Ames, et al.
Published: (2006-01-01)

A Snake Venom-Secreted Phospholipase A2 Induces Foam Cell Formation Depending on the Activation of Factors Involved in Lipid Homeostasis
by: Elbio Leiguez, et al.
Published: (2018-01-01)

Protective Effect of Cytosolic Phospholipase A2 Inhibition against Inflammation and Degeneration by Promoting Regulatory T Cells in Rats with Experimental Autoimmune Encephalomyelitis
by: Dan Yang, et al.
Published: (2014-01-01)

Annexin I and dexamethasone effects on phospholipase and cyclooxygenase activity in human synoviocytes
by: Annaleise V. Sampey, et al.
Published: (2000-01-01)

n-3 Polyunsaturated Fatty Acid Supplementation Has No Effect on Postprandial Triglyceride-Rich Lipoprotein Kinetics in Men with Type 2 Diabetes
by: André J. Tremblay, et al.
Published: (2016-01-01)

Correlation Between the Ratio of Uric Acid to High-Density Lipoprotein Cholesterol (UHR) and Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus:A Cross-Sectional Study
by: Wang L, et al.
Published: (2025-01-01)

Resistance Training and Older Adults with Type 2 Diabetes Mellitus: Strength of the Evidence
by: Nina Hovanec, et al.
Published: (2012-01-01)

Responses of Phospholipase D and Antioxidant System to Mechanical Wounding in Postharvest Banana Fruits
by: Li Li, et al.
Published: (2017-01-01)

Renal Function and Ultrasound Imaging in Elderly Subjects
by: Luca Zanoli, et al.
Published: (2014-01-01)

Factors Associated with the Decline of Kidney Function Differ among eGFR Strata in Subjects with Type 2 Diabetes Mellitus
by: Shu Meguro, et al.
Published: (2012-01-01)

Importance of Self-Care in Elderly Adults with Diabetes Mellitus
by: Ydalsys Naranjo Hernández, et al.
Published: (2016-09-01)

Phospholipase D, a Novel Therapeutic Target Contributes to the Pathogenesis of Neurodegenerative and Neuroimmune Diseases
by: Weiwei Zhang, et al.
Published: (2024-01-01)

A Cross-Sectional Study Demonstrating Increased Serum Amyloid A Related Inflammation in High-Density Lipoproteins from Subjects with Type 1 Diabetes Mellitus and How This Association Was Augmented by Poor Glycaemic Control
by: Jane McEneny, et al.
Published: (2015-01-01)

Efficacy and safety of glucagon-like peptide-1 receptor agonists in the elderly versus non-elderly patients with type 2 diabetes mellitus: insights from a systematic review
by: Yao Wang, et al.
Published: (2024-06-01)